• Biocartis kondigt co-commercialisatie aan van de SeptiCyte® RAPID Test op Idylla™ (CE-IVD) en brengt update over COVID-19 impact

    Friday March 27th 2020

  • Bone Therapeutics appoints Stefanos Theoharis as Chief Business Officer

    Friday March 27th 2020

  • miDiagnostics Raises €14m to Accelerate the Commercialization of its Disruptive, Lab-quality Silicon Chip Diagnostics Platform

    Thursday March 26th 2020

  • “De toekomst van de Belgische life sciences ziet er rooskleurig uit”

    Thursday March 26th 2020

  • Urgent Call for Centrifuges

    Wednesday March 25th 2020

  • University hospital Ghent and VIB are testing medication to treat COVID-19-associated respiratory illness

    Wednesday March 25th 2020

  • ECCRT enters into an agreement with Qualitis for continuous online development of its staff

    Wednesday March 25th 2020

  • eTheRNA launches an international consortium and starts development of cross-strain protective CoV-2 mRNA vaccine for high risk populations

    Tuesday March 24th 2020

  • Your news here?

  • Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates.

    Tuesday March 24th 2020

  • Dr. Matthias Friebe joins Camel-IDS as acting Chief Technology Officer.

    Tuesday March 24th 2020

  • ElmediX wil coronavirus stoppen door patiënten gecontroleerd op te warmen.

    Monday March 23rd 2020


Strategic Partners